Mechanisms underlying fibronectin-induced up-regulation of P2X 4R expression in microglia: Distinct roles of PI3K-Akt and MEK-ERK signalling pathways

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3251-3259

  Tsuda, Makoto ^a   Toyomitsu, Emika ^a   Kometani, Miho ^a   Tozaki Saitoh, Hidetoshi ^a   Inoue, Kazuhide ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Fibronectin; Gene expression; Microglia; P2X 4 receptor; Post transcriptional regulation; Signal transduction

Indexed keywords

FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PURINERGIC P2X4 RECEPTOR;

ANIMAL; ARTICLE; CHEMISTRY; DEGENERATIVE DISEASE; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MICROGLIA; PATHOLOGY; RAT; RNA PROCESSING; SIGNAL TRANSDUCTION; UPREGULATION; WISTAR RAT;

ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBRONECTINS; IMMUNOHISTOCHEMISTRY; MAP KINASE KINASE KINASES; MICROGLIA; NEURODEGENERATIVE DISEASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2X4; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77449099299     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00719.x     Document Type: Article

References (70)

1. Nakajima K, Kohsaka S. Characterization of brain microglia and the biological significance in the central nervous system. Adv Neurol. 1993, 60:734-43.
2. Streit WJ. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia. 2002, 40:133-9.
3. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007, 10:1387-94.
4. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-8.
5. Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol. 1999, 58:233-47.
6. Streit WJ, Walter SA, Pennell NA. Reactive microgliosis. Prog Neurobiol. 1999, 57:563-81.
7. Davalos D, Grutzendler J, Yang G. ATP mediates rapid microglial response to local brain injur. in vivo. Nat Neurosci. 2005, 8:752-8.
8. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature. 2007, 446:1091-5.
9. Nasu-Tada K, Koizumi S, Inoue K. Involvement of beta1 integrin in microglial chemotaxis and proliferation on fibronectin: different regulations by ADP through PKA. Glia. 2005, 52:98-107.
10. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov. 2008, 7:575-90.
11. Fields RD, Burnstock G. Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci. 2006, 7:423-36.
12. Inoue K, Koizumi S, Tsuda M. The role of nucleotides in the neuron-glia communication responsible for the brain functions. J Neurochem. 2007, 102:1447-58.
13. Khakh BS, North RA. P2X receptors as cell-surface ATP sensors in health and disease. Nature. 2006, 442:527-32.
14. Inoue K. Microglial activation by purines and pyrimidines. Glia. 2002, 40:156-63.
15. Inoue K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther. 2006, 109:210-26.
16. Haynes SE, Hollopeter G, Yang G. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci. 2006, 9:1512-9.
17. Honda S, Sasaki Y, Ohsawa K. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci. 2001, 21:1975-82.
18. Kurpius D, Nolley EP, Dailey ME. Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus. Glia. 2007, 55:873-84.
19. Ohsawa K, Irino Y, Nakamura Y. Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia. 2007, 55:604-16.
20. Tsuda M, Shigemoto-Mogami Y, Koizumi S. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature. 2003, 424:778-83.
21. Coull JA, Beggs S, Boudreau D. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005, 438:1017-21.
22. Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in " small" glia. Trends Neurosci. 2005, 28:101-7.
23. Cavaliere F, Florenzano F, Amadio S. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience. 2003, 120:85-98.
24. Guo LH, Trautmann K, Schluesener HJ. Expression of P2X4 receptor in rat C6 glioma by tumor-associated macrophages and activated microglia. J Neuroimmunol. 2004, 152:67-72.
25. Guo LH, Trautmann K, Schluesener HJ. Expression of P2X4 receptor by lesional activated microglia during formalin-induced inflammatory pain. J Neuroimmunol. 2005, 163:120-7.
26. Zhang Z, Zhang Z, Artelt M. Dexamethasone attenuates early expression of three molecules associated with microglia/macrophages activation following rat traumatic brain injury. Acta Neuropathol. 2007, 113:675-82.
27. Schwab JM, Guo L, Schluesener HJ. Spinal cord injury induces early and persistent lesional P2X4 receptor expression. J Neuroimmunol. 2005, 163:185-9.
28. Zhang Z, Zhang ZY, Fauser U. Mechanical allodynia and spinal up-regulation of P2X4 receptor in experimental autoimmune neuritis rats. Neuroscience. 2008, 152:495-501.
29. Nasu-Tada K, Koizumi S, Tsuda M. Possible involvement of increase in spinal fibronectin following peripheral nerve injury in upregulation of microglial P2X4, a key molecule for mechanical allodynia. Glia. 2006, 53:769-75.
30. Tsuda M, Toyomitsu E, Komatsu T. Fibronectin/integrin system is involved in P2X(4) receptor upregulation in the spinal cord and neuropathic pain after nerve injury. Glia. 2008, 56:579-85.
31. Tsuda M, Tozaki-Saitoh H, Masuda T. Lyn tyrosine kinase is required for P2X(4) receptor upregulation and neuropathic pain after peripheral nerve injury. Glia. 2008, 56:50-8.
32. Nakajima K, Shimojo M, Hamanoue M. Identification of elastase as a secretory protease from cultured rat microglia. J Neurochem. 1992, 58:1401-8.
33. Suh HS, Kim MO, Lee SC. Inhibition of granulocyte-macrophage colony-stimulating factor signaling and microglial proliferation by anti-CD45RO: role of Hck tyrosine kinase and phosphatidylinositol 3-kinase/Akt. J Immunol. 2005, 174:2712-9.
34. Kim WK, Hwang SY, Oh ES. TGF-beta1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity. J Immunol. 2004, 172:7015-23.
35. Suzuki T, Hide I, Ido K. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci. 2004, 24:1-7.
36. Komarov PG, Komarova EA, Kondratov RV. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 1999, 285:1733-7.
37. Bae BI, Xu H, Igarashi S. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron. 2005, 47:29-41.
38. Wang J, Sampath A, Raychaudhuri P. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells. Oncogene. 2001, 20:4740-9.
39. Chen Z, Knutson E, Wang S. Stabilization of p53 in human cytomegalovirus-initiated cells is associated with sequestration of HDM2 and decreased p53 ubiquitination. J Biol Chem. 2007, 282:29284-95.
40. Andersson K, Sundler R. Posttranscriptional regulation of TNFalpha expression via eukaryotic initiation factor 4E (eIF4E) phosphorylation in mouse macrophages. Cytokine. 2006, 33:52-7.
41. Knauf U, Tschopp C, Gram H. Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2. Mol Cell Biol. 2001, 21:5500-11.
42. Thompson T, Tovar C, Yang H. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J Biol Chem. 2004, 279:53015-22.
43. Vassilev LT, Vu BT, Graves B. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004, 303:844-8.
44. Ohsawa K, Imai Y, Nakajima K. Generation and characterization of a microglial cell line, MG5, derived from a p53-deficient mouse. Glia. 1997, 21:285-98.
45. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999, 285:1028-32.
46. Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 2002, 4:E83-90.
47. Playford MP, Schaller MD. The interplay between Src and integrins in normal and tumor biology. Oncogene. 2004, 23:7928-46.
48. Shigemoto-Mogami Y, Koizumi S, Tsuda M. Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J Neurochem. 2001, 78:1339-49.
49. Holmberg CI, Tran SE, Eriksson JE. Multisite phosphorylation provides sophisticated regulation of transcription factors. Trends Biochem Sci. 2002, 27:619-27.
50. Grossman SR, Perez M, Kung AL. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell. 1998, 2:405-15.
51. Raught B, Gingras AC. eIF4E activity is regulated at multiple levels. Int J Biochem Cell Biol. 1999, 31:43-57.
52. Ueda T, Watanabe-Fukunaga R, Fukuyama H. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol. 2004, 24:6539-49.
53. Riley T, Sontag E, Chen P. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 2008, 9:402-12.
54. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer. 2002, 2:594-604.
55. Singh S, Upadhyay AK, Ajay AK. p53 regulates ERK activation in carboplatin induced apoptosis in cervical carcinoma: a novel target of p53 in apoptosis. FEBS Lett. 2007, 581:289-95.
56. Bragado P, Armesilla A, Silva A. Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis. 2007, 12:1733-42.
57. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998, 8:397-403.
58. Jeong SJ, Pise-Masison CA, Radonovich MF. Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene. 2005, 24:6719-28.
59. Kapila YL, Wang S, Dazin P. The heparin-binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells. J Biol Chem. 2002, 277:8482-91.
60. Zhou BP, Liao Y, Xia W. HER-2/neu induces p53 ubiquitinatio. via Akt-mediated MDM2 phosphorylation. Nat Cell Biol. 2001, 3:973-82.
61. Mayo LD, Donner DB. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci. 2002, 27:462-7.
62. Dumitru CD, Ceci JD, Tsatsanis C. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell. 2000, 103:1071-83.
63. Kelleher RJ 3rd, Govindarajan A, Tonegawa S. Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron. 2004, 44:59-73.
64. McKendrick L, Pain VM, Morley SJ. Translation initiation factor 4E. Int J Biochem Cell Biol. 1999, 31:31-5.
65. Waskiewicz AJ, Flynn A, Proud CG. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 1997, 16:1909-20.
66. Karni R, Gus Y, Dor Y. Active Src elevates the expression of beta-catenin by enhancement of cap-dependent translation. Mol Cell Biol. 2005, 25:5031-9.
67. Xiao YQ, Freire-de-Lima CG, Schiemann WP. Transcriptional and translational regulation of TGF-beta production in response to apoptotic cells. J Immunol. 2008, 181:3575-85.
68. Xu JT, Tu HY, Xin WJ. Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats. Exp Neurol. 2007, 206:269-79.
69. Ossipov MH, Bazov I, Gardell LR. Control of chronic pain by the ubiquitin proteasome system in the spinal cord. J Neurosci. 2007, 27:8226-37.
70. Zhuang ZY, Gerner P, Woolf CJ. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain. 2005, 114:149-59.